{"id":3452,"date":"2026-02-04T16:11:42","date_gmt":"2026-02-04T15:11:42","guid":{"rendered":"https:\/\/www.amsvita.com\/en\/?p=3452"},"modified":"2026-03-28T16:13:13","modified_gmt":"2026-03-28T15:13:13","slug":"autologous-regenerative-therapy-in-orthobiology","status":"publish","type":"post","link":"https:\/\/www.amsvita.com\/en\/news\/autologous-regenerative-therapy-in-orthobiology\/","title":{"rendered":"Autologous Regenerative Therapy in Orthobiology"},"content":{"rendered":"\n

Definition and scope of orthobiologics<\/strong><\/h2>\n\n\n\n

Autologous Regenerative Therapy is described as an innovative medical discipline that aims to regenerate injured tissues or to stimulate their repair, using the same natural principles of tissue engineering within an easy, reproducible, and fast procedure. The technique is based on the use of the patient\u2019s own cells, in particular autologous mesenchymal stem cells<\/strong>, in a single medical procedure to support tissue healing. In this context, orthobiologic approaches are directed at musculoskeletal structures affected by degenerative or traumatic processes, with the goal of enhancing intrinsic repair mechanisms rather than only providing symptomatic relief. Autologous adipose tissue and its stromal vascular fraction are central components of this strategy, given their cellular composition and biological activity in musculoskeletal environments.<\/p>\n\n\n\n

Within orthobiology, osteoarthritis represents a major field of application because it is a complex musculoskeletal disorder characterized by degeneration of the articular cartilage, joint pain, dysfunction, and progressive loss of cartilage. Conventional conservative treatments for osteoarthritis, including physical therapy, weight loss, lifestyle changes, pharmacologic therapies, steroid injections, intra-articular hyaluronic acid injections, and surgery, are largely palliative and do not reverse or repair the degenerative nature of the disease. This therapeutic gap has driven interest in orthobiologic strategies that can contribute to tissue repair and regeneration, particularly in weight-bearing joints such as the knees and hips that are exposed to chronic high stress.<\/p>\n\n\n\n

The scope of orthobiologics in this setting includes the intra-articular use of autologous micro-fragmented adipose tissue, which is naturally rich in adipose-derived stem cells<\/strong>, cytokines, growth factors, pre-adipocytes, and mature adipocytes. These components collectively support regenerative processes through differentiation potential and paracrine signaling. Adipose-derived stem cells have been shown to differentiate into multiple cell types, including adipocytes, chondrocytes, myocytes, hepatocytes, and endothelial cells, and to secrete bioactive molecules that stimulate angiogenesis and exert antifibrotic, antiapoptotic, and immunomodulatory effects. Such properties align closely with the objectives of orthobiologic therapies, which seek to modify the disease environment and promote structural and functional recovery.<\/p>\n\n\n\n

Orthobiologic interventions also encompass the technical aspects of tissue harvesting and processing, as these influence cell viability and regenerative potential. Studies evaluating adipose tissue harvested with small microcannulas have demonstrated that minimally invasive techniques and minimal manipulation can yield micro-fragmented adipose tissue with a good amount of viable cells, supporting its role as a promising source for regenerative treatments. These findings reinforce the concept that orthobiology is not limited to the choice of tissue source, but also includes optimization of procedural steps to preserve the biological integrity of the graft.<\/p>\n\n\n\n

Biological products and healing promotion<\/strong><\/h2>\n\n\n\n

The biological foundation of Autologous Regenerative Therapy in orthobiology relies on the properties of mesenchymal stem cells<\/strong> and the stromal vascular fraction contained in adipose tissue. Mesenchymal stem cells are multipotent cells present in many organs and tissues, and adipose tissue has been identified as a particularly promising source. Adipose-derived mesenchymal stem cells can be isolated from the stromal vascular fraction, which contains interrelated cell populations such as adipocyte progenitors, pericytes, endothelial progenitor cells, and transit-amplifying cells. These cells exhibit differentiation potential toward osteogenic, chondrogenic, myogenic, hepatogenic, and endothelial lineages, both in vitro and in vivo, providing a cellular substrate for regeneration of mesenchymal tissues including cartilage, bone, and soft tissues.<\/p>\n\n\n\n

Beyond differentiation, adipose-derived stem cells and associated stromal cells secrete a wide variety of factors with antifibrotic, antiapoptotic, immunomodulatory, and pro-angiogenic properties. These secreted bioactive molecules contribute to tissue repair by stimulating angiogenesis, supporting revascularization of grafted tissue, and modulating local inflammatory responses. In clinical contexts, adipose tissue implantation has been used to improve skin trophism, accelerate closure of complex wounds or ulcers, and enhance skin appearance after radiotherapy damage, illustrating the broader regenerative potential of these biological products. The same mechanisms are relevant when these cells and tissues are applied to musculoskeletal structures, where vascular support and modulation of inflammation are critical to healing.<\/p>\n\n\n\n

Micro-fragmented adipose tissue, harvested with guided microcannulas and subjected to minimal manipulation, has been shown to contain viable and proliferative cells without the need for enzymatic digestion. Comparative analyses indicate that adipose tissue harvested with small side-port microcannulas yields a comparable amount of viable cells to tissue processed with enzymatic digestion, while avoiding regulatory issues associated with enzymatic procedures. The presence of viable cells within the tissue itself, and cells released by the mechanical action of the cannula, supports the use of this micro-fragmented adipose tissue as a biological product capable of promoting regeneration in a variety of clinical settings.<\/p>\n\n\n\n

In the specific context of osteoarthritis, intra-articular injection of autologous fat micrograft leverages both the cellular and mechanical properties of adipose tissue. The reparative effect of autologous fat graft on damaged tissue is complemented by its natural lubricating effect on the joint, which may contribute to symptom relief. Clinical experience with intra-articular fat micrograft in hip and knee osteoarthritis has shown improvements in range of motion, reductions in stiffness, and progressive reductions in pain over follow-up intervals, with a high proportion of patients reporting satisfaction and improved quality of life. These observations suggest that the biological products used in Autologous Regenerative Therapy can promote functional recovery and symptom control in degenerative joint disease.<\/p>\n\n\n\n

Role of adipose and bone marrow derived therapies<\/strong><\/h2>\n\n\n\n

Autologous Regenerative Therapy in orthobiology has increasingly focused on adipose tissue as a practical and biologically rich source of regenerative cells. Human adipose tissue has been described as a source of multipotent mesenchymal stromal cells similar to those found in bone marrow, with the advantage of relative abundance and accessibility. The stromal vascular fraction of adipose tissue contains adipose-derived stem cells, cytokines, growth factors, pre-adipocytes, and mature adipocytes, all of which contribute to its regenerative profile. These adipose-derived stem cells demonstrate the capacity to differentiate into multiple mesenchymal and non-mesenchymal lineages and to secrete bioactive molecules that support angiogenesis and exert antifibrotic, antiapoptotic, and immunomodulatory effects, making adipose tissue a central component of orthobiologic strategies.<\/p>\n\n\n\n

The concept of mesenchymal stem cells as trophic mediators has further clarified their role in regenerative therapies. Rather than acting solely through direct differentiation into target tissues, mesenchymal stem cells, including those derived from adipose tissue, exert significant effects through paracrine signaling that modulates the local microenvironment. This includes influencing inflammation, fibrosis, and vascularization, which are key processes in the pathogenesis and progression of osteoarthritis and other musculoskeletal disorders. Evidence of multiple types of multipotent cells within adult human adipose tissue, and the identification of a perivascular origin for mesenchymal stem cells in multiple human organs, support the view that these cells are widely distributed and can be mobilized for therapeutic purposes.<\/p>\n\n\n\n

In orthopedics, bone marrow\u2013derived mesenchymal stem cells have historically played a pioneering role in translational cell therapy. Stem cells have been used in the treatment of avascular bone necrosis, osteochondral defects, pseudoarthrosis, and traumatic cartilage defects, demonstrating the potential of bone marrow\u2013derived cells to contribute to structural repair. At the same time, adipose-derived mesenchymal stem cells have emerged as an alternative source with similar multipotent characteristics and trophic functions. The recognition that adipose tissue contains mesenchymal stromal cells comparable to those from bone marrow has expanded the therapeutic options for Autologous Regenerative Therapy, allowing clinicians to select tissue sources based on accessibility, cell yield, and procedural considerations.<\/p>\n\n\n\n

Technical studies on adipose tissue harvesting have shown that guided microcannulas with small side-port holes can obtain adipose tissue containing viable cells suitable for regenerative applications without the need for enzymatic digestion. This minimally invasive approach aligns with the principles of autologous therapies, which emphasize safety, standardization, and preservation of biological function. The resulting micro-fragmented adipose tissue is considered a promising source for regenerative treatments in both aesthetic and musculoskeletal indications, reinforcing the role of adipose-derived therapies alongside bone marrow\u2013based approaches within the broader field of orthobiology.<\/p>\n\n\n\n

Scientific rationale and evidence<\/strong><\/h2>\n\n\n\n

The scientific rationale for Autologous Regenerative Therapy in orthobiology is grounded in the pathophysiology of osteoarthritis and the biological properties of mesenchymal stem cells. Osteoarthritis is characterized by an imbalance between repair and destruction within the joint, with poor intrinsic healing power and limited regeneration due to poor vascularization and the absence of direct access to progenitor cells of the bone marrow. Autologous Regenerative Therapy seeks to address this deficit by introducing mesenchymal stem cells, particularly adipose-derived stem cells, into the joint environment to support repair and modulate disease processes. The ability of mesenchymal cells to differentiate in response to environmental signals and specific growth factors makes them suitable elements to stimulate healing in lesions involving different tissues, including cartilage, tendons, and bone.<\/p>\n\n\n\n

Experimental and clinical data have demonstrated that adipose-derived mesenchymal stem cells possess multilineage differentiation potential and secrete bioactive molecules that promote angiogenesis and exert antifibrotic, antiapoptotic, and immunomodulatory effects. Foundational studies identified human adipose tissue as a source of multipotent stem cells and described their capacity to differentiate into various lineages, including osteogenic and chondrogenic cells. Subsequent work has shown that adult human adipose tissue contains several types of multipotent cells and that mesenchymal stem cells may have a perivascular origin in multiple organs, supporting their widespread presence and potential for therapeutic mobilization. These findings provide a mechanistic basis for the use of adipose-derived cells in regenerative therapies targeting musculoskeletal tissues.<\/p>\n\n\n\n

Clinical evidence for autologous adipose-based therapies in osteoarthritis includes observational data on intra-articular injection of fat micrograft in hip and knee osteoarthritis. In a cohort of 250 patients with initial-stage degenerative osteoarthritis of the hips and\/or knees, treated with a standardized device for autologous fat micrograft preparation, postoperative assessments showed an average increase of 10 degrees in range of motion at three months, reductions in stiffness, and progressive reductions in pain measured by the Visual Analog Scale, with the best pain scores at six months. One year after treatment, 85% of patients reported satisfaction, with considerable improvement in pain and quality of life. The donor site course was generally uneventful, with minimal discomfort, and the injected joints showed only transient swelling and low-grade pain for a few days, without reported infections or major complications.<\/p>\n\n\n\n

Additional support for the feasibility of adipose-based regenerative therapies comes from studies evaluating cell viability in harvested adipose tissue. Comparative analyses of adipose tissue obtained with small microcannulas versus standard liposuction followed by enzymatic digestion have shown that microcannula-harvested tissue contains viable and proliferative cells, with cell viability at 72 hours comparable to stromal vascular fraction cells derived by enzymatic digestion. These findings indicate that minimally manipulated micro-fragmented adipose tissue can provide a biologically active graft suitable for regenerative applications, while avoiding regulatory constraints associated with enzymatic processing. Collectively, these experimental and clinical data underpin the scientific rationale for Autologous Regenerative Therapy in orthobiology and support its continued investigation in musculoskeletal disorders.<\/p>\n\n\n\n

Use in orthopedic and sports medicine<\/strong><\/h2>\n\n\n\n

In orthopedics, Autologous Regenerative Therapy has been applied to conditions where conventional treatments do not reverse underlying degeneration, particularly osteoarthritis of weight-bearing joints. Cartilage repair has played a pioneering role in the translational application of cell therapy, and mesenchymal stem cells have been used in the treatment of avascular bone necrosis, osteochondral defects, pseudoarthrosis, and traumatic cartilage defects. Within this framework, intra-articular injection of autologous micro-fragmented adipose tissue represents a minimally invasive option aimed at improving joint function and symptoms by harnessing the regenerative and trophic properties of adipose-derived stem cells and associated stromal elements.<\/p>\n\n\n\n

Clinical experience with intra-articular fat micrograft in hip and knee osteoarthritis illustrates how Autologous Regenerative Therapy can be integrated into orthopedic practice. Patients with initial-stage degenerative osteoarthritis of the hips and knees underwent imaging-based grading and then received intra-articular injections of autologous fat micrograft prepared with a standardized device. Follow-up evaluations at one, three, six, and twelve months documented improvements in range of motion and reductions in stiffness, with pain scores improving progressively and reaching their best levels at six months. The majority of procedures involved the knees, with a smaller proportion targeting the hips, reflecting the high prevalence of knee osteoarthritis in clinical practice.<\/p>\n\n\n\n

The postoperative course associated with these procedures has been characterized by favorable tolerability. Donor sites typically exhibited minimal discomfort, edema, and ecchymosis, without major complications. Injected joints showed transient swelling and low-grade pain lasting a few days, and the injected autologous material was well tolerated. Over longer follow-up, a subset of patients proceeded to joint replacement surgery, predominantly older individuals with more advanced osteoarthritis, while many others reported sustained improvements in pain and quality of life. These observations suggest that intra-articular autologous adipose-based therapies can be incorporated into the therapeutic continuum for degenerative joint disease, potentially contributing to symptom control and functional maintenance.<\/p>\n\n\n\n

Beyond osteoarthritis, the regenerative properties of adipose-derived cells have been explored in other clinical areas relevant to musculoskeletal and functional recovery, including the treatment of radiotherapy-induced tissue damage, chronic ulcers, and gynecologic conditions. In these settings, adipose tissue grafts and stromal vascular fraction cells have been associated with improved tissue trophism, accelerated healing, and symptomatic relief. Although these indications are outside the strict domain of sports medicine, they reinforce the broader applicability of adipose-based Autologous Regenerative Therapy to conditions characterized by impaired tissue repair. The shared mechanisms of angiogenesis, immunomodulation, and antifibrotic activity are also pertinent to sports-related injuries that involve soft tissue and cartilage damage.<\/p>\n\n\n\n

Future developments and innovation<\/strong><\/h2>\n\n\n\n

Future developments in Autologous Regenerative Therapy in orthobiology are closely linked to advances in the characterization and processing of adipose tissue and its cellular components. Innovative harvesting systems, such as guided microcannulas and devices designed to obtain micro-fragmented adipose tissue with preserved stromal vascular fraction, aim to standardize procedures and optimize cell viability. Studies using analytical platforms to characterize lipoaspirate composition have demonstrated that adipose tissue harvested with specific systems can deliver viable adipocytes and stromal cells, including adipose-derived stem cells and pericytes, intended to restore and regenerate tissue. These technologies provide detailed information on tissue composition and support the refinement of protocols for clinical use.<\/p>\n\n\n\n

At the cellular level, ongoing research is focused on better understanding the stemness characteristics of adipose-derived stromal cells obtained with different harvesting techniques. Investigations have shown that adipose-derived stromal cells isolated from tissue harvested with various microcannula sizes retain the ability to form colony-forming units and to differentiate toward adipogenic, osteogenic, and chondrogenic lineages. Further studies are being directed at evaluating the expression of stem cell genes involved in self-renewal, such as Oct4, Sox2, and Nanog, to determine whether differences in harvesting methods translate into functional differences in regenerative potential. Such insights may guide the selection of specific techniques for particular clinical indications within orthobiology.<\/p>\n\n\n\n

Regulatory considerations also influence innovation in Autologous Regenerative Therapy. The demonstration that adipose tissue harvested with microcannulas and without enzymatic manipulation contains viable and proliferative cells supports the use of minimally manipulated tissue in regenerative applications, which may be more compatible with existing regulatory frameworks. By avoiding enzymatic digestion, these approaches can simplify clinical workflows while maintaining biological efficacy. Continued research is needed to expand the evidence base, including larger cohorts, control groups, and longer follow-up, to refine indications and optimize treatment protocols in musculoskeletal disorders.<\/p>\n\n\n\n

As the understanding of mesenchymal stem cell biology evolves, Autologous Regenerative Therapy in orthobiology is likely to integrate more precise characterization of cell populations, improved delivery systems, and combination strategies that leverage both structural and trophic effects. The recognition of mesenchymal stem cells as trophic mediators, and the identification of multiple multipotent cell types within adipose tissue, provide a conceptual framework for therapies that aim not only to replace damaged tissue but also to modulate the joint microenvironment. Within this evolving landscape, autologous adipose-derived therapies, including intra-articular micro-fragmented fat injections, are positioned as key components of regenerative strategies for degenerative musculoskeletal conditions.<\/p>\n\n\n\n

Sources (Bibliography)<\/strong><\/h2>\n\n\n\n
    \n
  • Trentani P, Meredi E, Zarantonello P, Gennai A. Role of Autologous Micro-Fragmented Adipose Tissue in Osteoarthritis Treatment. Journal of Personalized Medicine, 2024.<\/li>\n\n\n\n
  • Gennai A, Bovani B, Colli M, Melfa F, Piccolo D, Russo R, Roda B, Zattoni A, Reschiglian P, Zia S. Comparison of Harvesting and Processing Technique for Adipose Tissue Graft: Evaluation of Cell Viability. International Journal of Regenerative Medicine, 2021.<\/li>\n\n\n\n
  • Rossi M, Alviano F, Ricci F, et al. Characterization of Tissue and Stromal Cells for Facial Aging Treatment. 2020.<\/li>\n\n\n\n
  • Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 2001.<\/li>\n\n\n\n
  • Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 2002.<\/li>\n\n\n\n
  • Zuk PA. The adipose-derived stem cell: looking back and looking ahead. Molecular Biology of the Cell, 2010.<\/li>\n\n\n\n
  • Tallone T, Realini C, Bohmler A, Kornfeld C, Vassalli G, Moccetti T, Bardelli S, Soldati G. Adult human adipose tissue contains several types of multipotent cells. Journal of Cardiovascular Translational Research, 2011.<\/li>\n\n\n\n
  • Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. Journal of Cell Biochemistry, 2006.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

    Definition and scope of orthobiologics Autologous Regenerative Therapy is described as an innovative medical discipline that aims to regenerate injured tissues or to stimulate their repair, using the same natural principles of tissue engineering within an easy, reproducible, and fast procedure. The technique is based on the use of the patient\u2019s own cells, in particular […]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[59,8],"tags":[57,58],"_links":{"self":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3452"}],"collection":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/comments?post=3452"}],"version-history":[{"count":1,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3452\/revisions"}],"predecessor-version":[{"id":3453,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3452\/revisions\/3453"}],"wp:attachment":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/media?parent=3452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/categories?post=3452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/tags?post=3452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}